Research output per year
Research output per year
Personal profile
Biography
Dr Mahon is a Lecturer Above the Bar in the Discipline of Economics at University of Galway and is currently Programme Director for the MSc in Health Economics. He is chair of the Health Economics Association of Ireland and is a member of the National Screening Advisory Committee of Ireland. Dr Mahon spent 10 years in various private sector roles, latterly as Head of Value and Access for Novartis Global Business Services, before joining University of Galway in January 2024.
Research Interests
Current research interests include:
- Estimations of a cost-effectiveness threshold for new health technologies in Ireland
- Accounting for aspects of equity in health economic evaluation
- Methods for early value assessment in healthcare
Related documents
Education/Academic qualification
B.Sc., M.Sc., PhD
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being -
SDG 8 Decent Work and Economic Growth -
SDG 10 Reduced Inequalities -
SDG 12 Responsible Consumption and Production -
SDG 13 Climate Action
Fingerprint
Dive into the research topics where Ronan Mahon is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Implications of Incorporating Environmental Sustainability Into Health Technology Assessment for Digital Health Technologies
Di Bidino, R., Dutta Majumdar, A., Pegg, M., Mahon, R., Papavero, S. C. & Mueller, D., Apr 2026, In: Value in Health. 29, 4, p. 595-599 5 p.Research output: Contribution to a Journal (Peer & Non Peer) › Article › peer-review
3 Citations (Scopus) -
Recommendations for the use of early cost-effectiveness analysis to inform the health technology development process with an application to cutaneous squamous cell carcinoma
Mahon, R., Choudhury, S. P., Kumar Dutta, S., Dutta Majumdar, A., Ghosh, B., Demla, C., Thomas, A. & Dey, D., 2026, In: International Journal of Technology Assessment in Health Care.Research output: Contribution to a Journal (Peer & Non Peer) › Article › peer-review
Open AccessFile -
Cost effectiveness of early metformin in addition to usual care in the reduction of gestational diabetes mellitus effects (EMERGE)-A randomised placebo-controlled clinical trial
Gillespie, P., Mahon, R., Newman, C., Alvarez-Iglesias, A., Ferguson, J., Smyth, A., O'Shea, P., Devane, D., Egan, A., Ó Donnell, M. & Dunne, F., 2 Apr 2025, (E-pub ahead of print) In: Diabetic Medicine. 42, 6, p. e70036 e70036.Research output: Contribution to a Journal (Peer & Non Peer) › Article › peer-review
Open AccessFile3 Downloads (Pure) -
Looking back to move forward: can historical clinical trial data and machine learning drive change in participant recruitment in anticipation of future value assessments?
Choudhury, S. P., Majumdar, A. D., Mahon, R., Dutta, S. K. & Bhattacharyya, S., 15 Oct 2025, In: Trials.Research output: Contribution to a Journal (Peer & Non Peer) › Article › peer-review
-
The costs and benefits of an early access scheme for oncology medicines in Ireland
Morris, K., Pennington, M., Whitelegg, C., Parkes, L. & Mahon, R., 31 Oct 2025Research output: Other contribution (Published) › Other contribution
Activities
-
PhD Student - Marina Rosca
Mahon, R. (Primary Supervisor)
1 Sept 2025Activity: Other › Current Postgraduates (Research) Supervised
-
PhD Student - Cillian Copeland
Mahon, R. (Primary Supervisor)
1 Jun 2025Activity: Other › Current Postgraduates (Research) Supervised
-
PhD Student - Orla Jenkins
Mahon, R. (Primary Supervisor)
1 Sept 2024Activity: Other › Current Postgraduates (Research) Supervised
-